Researchers Halt Trial of Promising Sickle Cell Treatment

Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.Sickle Cell Anemia, Leukemia, Bone Marrow, Genetic Engineering, Clinical Trials, Bluebird Bio Inc, Williams, David II, DNA (Deoxyribonucleic Acid), National Heart, Lung and Blood Institute, Busulfan, Drugs (Pharmaceuticals)Read More

Leave a Reply

Your email address will not be published.